medigraphic.com
ISSN 0016-3813 (Print)

2014, Number s1

<< Back Next >>

Gac Med Mex 2014; 150 (s1)

Prevalence and gravity of depression and anxiety in patients with obesity and type 2 diabetes: a study in the population of Tabasco, Mexico

Martínez HF, Tovilla ZCA, López NL, Juárez RIE, Jiménez SMA, González GCP, Pool GS

Language: Spanish
References: 31
Page: 101-106
PDF size: 211.55 Kb.


ABSTRACT

Aims: The aim of this study was to assess the prevalence of anxiety and depression in groups of obese and normal-weight individuals with type 2 diabetes. Also, to analyze the severity of depression in type 2 diabetics by taking into account the body mass index in people with this condition. Methods: This study included 702 patients with type 2 diabetes, 236 with normal weight, and 231 with obesity. All participants completed a demographic questionnaire, the Hamilton Anxiety Rating Scale and the Hamilton Depression Rating Scale. Results: In patients with obesity, 48.48% (95% CI: 41.82-55.14) were positive for anxiety and 49.78% (95% CI: 43.11-56.44) for depression. A significant correlation existed between the Hamilton Depression Rating Scale and body mass index with a correlation coefficient of 0.11 (p = 0.003). Also, a significant correlation coefficient equal to 0.107 (p = 0.005) between the Hamilton Anxiety Rating Scale and body mass index was found. In addition, when we analyzed depression scores, significant differences were encountered for gender between normal-weight and obesity groups in the range of severe (p = 0.01) and very severe (p = 0.04) cases. Conclusion: In view of the existing relationships observed among obesity, depression, anxiety, and gender in type 2 diabetics, we consider that a psychological intervention is necessary for an integral management of these patients.


REFERENCES

  1. Khuwaja AK, Lalani S, Dhanani R, Azam IS, Rafique G, White F. Anxiety and depression among outpatients with type 2 diabetes: A multi-centre study of prevalence and associated factors. Diabetol Metab Syndr. 2010;2;72.

  2. Olaiz G, Rivera J, Shamah T, et al. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública; 2006.

  3. Hernández-Ávila M, Gutiérrez JP, Reynoso-Noverón N. [Diabetes mellitus in Mexico. Status of the epidemic]. Salud Publica Mex. 2013;55 Suppl 2:S129-36.

  4. Rodríguez MHy, Lazcano E, Prado BH, Abúndez CO. Encuesta Nacional de Salud y Nutrición 2006. Resultados por entidad federativa, Tabasco. Cuernavaca, México: Instituto Nacional de Salud Pública-Secretaría de Salud; 2007.

  5. McDade-Montez EA, Watson D. Examining the potential influence of diabetes on depression and anxiety symptoms via multiple sample confirmatory factor analysis. Ann Behav Med. 2011;42(3):341-51.

  6. Kim TS, Jeong SH, Kim JB, et al. The clinical research center for depression study: baseline characteristics of a korean long-term hospital- based observational collaborative prospective cohort study. Psychiatry Investig. 2011;8(1):1-8.

  7. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64(12):1465-75.

  8. Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12): 2398-403.

  9. Trento M, Raballo M, Trevisan M, et al. A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes. Acta Diabetol. 2012;49(3):199-203.

  10. Labad J, Price JF, Strachan MW, et al. Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia. 2010;53(3):467-71. Tabla 4. Distribución de pacientes con diabetes de tipo 2 que coinciden para depresión y ansiedad Pacientes con depresión; n (%) Pacientes sin depresión; n (%) Pacientes con ansiedad 288 (41.0) 100 (14.2) Pacientes sin ansiedad 47 (6.79 267 (38.1) Gaceta Médica de México. 2014;150 Suppl 1 106

  11. Dogan Y, Onat A, Kaya H, Ayhan E, Can G. Depressive symptoms in a general population: associations with obesity, inflammation, and blood pressure. Cardiol Res Pract. 2011;2011:740957.

  12. Svenningsson I, Bjorkelund C, Marklund B, Gedda B. Anxiety and depression in obese and normal-weight individuals with diabetes type 2: A gender perspective. Scand J Caring Sci. 2012;26(2):349-54.

  13. Lisspers J, Nygren A, Soderman E. Hospital Anxiety and Depression Scale (HAD): some psychometric data for a Swedish sample. Acta Psychiatr Scand. 1997;96(4):281-6.

  14. Balhara YP, Sagar R. Correlates of anxiety and depression among patients with type 2 diabetes mellitus. Indian J Endocrinol Metab. 2011;15(Suppl 1):S50-4.

  15. Roupa Z, Koulouri A, Sotiropoulou P, et al. Anxiety and depression in patients with type 2 diabetes mellitus, dependind on sex and body mass index. Health Science Journal. 2009;3:32-40.

  16. Wu SF, Young LS, Yeh FC, Jian YM, Cheng KC, Lee MC. Correlations among social support, depression, and anxiety in patients with type-2 diabetes. J Nurs Res. 2013;21(2):129-38.

  17. Tovilla-Zarate C, Juarez-Rojop I, Peralta Jimenez Y, et al. Prevalence of Anxiety and Depression among Outpatients with Type 2 Diabetes in the Mexican Population. PLoS One. 2012;7(5):e36887.

  18. Pulido-Criollo F, Rodriguez-Landa JF, Colorado-Martinez MP. [Sociodemographic factors associated with symptoms of depression in a sample women held at two prisons in Mexico]. Rev Panam Salud Publica. 2009;26(3):209-15.

  19. Sadeghi M, Roohafza H, Afshar H, et al. Relationship between depression and apolipoproteins A and B: a case-control study. Clinics (Sao Paulo). 2011;66(1):113-7.

  20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.

  21. Shear MK, Vander Bilt J, Rucci P, et al. Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety. 2001;13(4):166-78.

  22. Kummer A, Cardoso F, Teixeira AL. Generalized anxiety disorder and the Hamilton Anxiety Rating Scale in Parkinson’s disease. Arq Neuropsiquiatr. 2010;68(4):495-501.

  23. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370(9590):851-8.

  24. Stein DJ, Gureje O. Depression and anxiety in the developing world: is it time to medicalise the suffering? Lancet. 2004;364(9430):233-4.

  25. Pouwer F. Should we screen for emotional distress in type 2 diabetes mellitus? Nat Rev Endocrinol. 2009;5(12):665-71.

  26. Bouwman V, Adriaanse MC, van ‘t Riet E, Snoek FJ, Dekker JM, Nijpels G. Depression, anxiety and glucose metabolism in the general dutch population: the new Hoorn study. PLoS One. 2010;5(4):e9971.

  27. Almawi W, Tamim H, Al-Sayed N, et al. Association of comorbid depression, anxiety, and stress disorders with Type 2 diabetes in Bahrain, a country with a very high prevalence of Type 2 diabetes. J Endocrinol Invest. 2008;31(11):1020-4.

  28. Iype T, Shaji SK, Balakrishnan A, Charles D, Varghese AA, Antony TP. Cognition in type 2 diabetes: Association with vascular risk factors, complications of diabetes and depression. Ann Indian Acad Neurol. 2009;12(1):25-7.

  29. Sacco WP, Wells KJ, Friedman A, Matthew R, Perez S, Vaughan CA. Adherence, body mass index, and depression in adults with type 2 diabetes: the mediational role of diabetes symptoms and self-efficacy. Health Psychol. 2007;26(6):693-700.

  30. Sacco WP, Wells KJ, Vaughan CA, Friedman A, Perez S, Matthew R. Depression in adults with type 2 diabetes: the role of adherence, body mass index, and self-efficacy. Health Psychol. 2005;24(6):630-4.

  31. Pouwer F, Geelhoed-Duijvestijn PH, Tack CJ, et al. Prevalence of comorbid depression is high in out-patients with Type 1 or Type 2 diabetes mellitus. Results from three out-patient clinics in the Netherlands. Diabet Med. 2010;27(2):217-24.




2020     |     www.medigraphic.com